4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-17-014088
CIK 0001516479operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 9:16 PM ET
Size
8.1 KB
Accession
0001209191-17-014088
Insider Transaction Report
Form 4
Del Fosse Franc
General Counsel
Transactions
- Award
Employee Stock Option (right to buy)
2017-02-21+56,000→ 56,000 totalExercise: $12.65Exp: 2027-02-20→ Common Stock (56,000 underlying) - Award
Restricted Stock Units
2017-02-21+14,000→ 14,000 total→ Common Stock (14,000 underlying)
Footnotes (3)
- [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on February 21, 2021.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Represents shares issuable upon the vesting of restricted stock units ("RSUs") awarded to the Reporting Person on February 21, 2017. The RSUs vest in 3 equal annual installments beginning on February 21, 2018 and will be fully vested on February 21, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 9:16 PM ET
- Size
- 8.1 KB